Skip to content
Home
Meetings Archive
Browse By Category
Browse By Keyword
Search
Home
Meetings Archive
Browse By Category
Browse By Keyword
Search
Search
2020-05-20T12:01:36-05:00
Search
Search by Abstract Number, Title, Keyword, or Authors
Search by...
All
Authors and Affiliations
Title
Abstract Number
Keyword
Category
All
Clinical Vignettes
Innovations
Research
Sub-Category
(Optional)
Select Sub-Category...
Adult
Communication
Consultative Medicine
Education
Finalist
Geriatrics
Other
Outcomes Research
Patient Safety
Pediatric
Pediatrics
Perioperative
Quality Improvement
Technology in Hospital Medicine
Transitions of Care
Translating Research into Practice
Uncategorized
Value in Hospital Medicine
Winners
Session Type
Select Session Type...
Oral Presentations
Plenary Presentations
Meeting
All Meetings
SHM Converge 2024
SHM Converge 2023
SHM Converge 2022
SHM Converge 2021
Hospital Medicine 2020, Virtual Competition
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Hospital Medicine 2015, March 29-April 1, National Harbor, Md.
Hospital Medicine 2014, March 24-27, Las Vegas, Nev.
Hospital Medicine 2013, May 16-19, National Harbor, Md.
Hospital Medicine 2012, April 1-4, San Diego, Calif.
Hospital Medicine 2011, May 10-13, Dallas, Texas.
Hospital Medicine 2010, April 8-11, Washington, D.C.
Hospital Medicine 2009, May 14-17, Chicago, Ill.
Hospital Medicine 2008, April 3-5, San Diego, Calif.
Hospital Medicine 2007, May 23-25, Dallas, Texas
Hospital Medicine 2006, May 3-5, Washington, D.C.
Search Results for
covid
Abstract Number: 85
EARLY TRIPPLE TREATMENT WITH CONVALESCENT PLASMA,TOCILIZUMAB AND CORTICOSTEROIDS IN MECHANICALLY VENTILATED PATENTS WITH SEVERE COVID-19:A CASE SERIES OF EIGHT PATIENTS
SHM Converge 2021
Background: Background: SARS-Cov-2 infection (COVID-19) can lead to severe respiratory illness characterized by diffuse pulmonary inflammation similar to what is seen in ARDS. The case series evaluates the additive anti-inflammatory effects of patients that received Tocilizumab, Convalescent Plasma and corticosteroids within 72 hours of hospital admission for critical COVID-19 disease. Methods: This is a retrospective […]
Abstract Number: 86
RISK FACTORS FOR 30-DAYS READMISSION OF PATIENTS WITH COVID19 INFECTION: A RETROSPECTIVE-PROSPECTIVE STUDY FROM THE CROSS COLLABORATIVE
SHM Converge 2021
Background: The number of survivors of an initial COVID-19 disease hospitalization is growing and further data describing clinical and sociodemographic risk factors for hospital readmissions is needed. The CROSS (COVID-19 Characteristics of Readmissions and Outcomes and Social Determinants of Health Study) Collaborative was developed in July 2020 and is a multidisciplinary, multi-hospital group dedicated to […]
Abstract Number: 87
COMPARISON OF ANTIBODY RESPONSE BETWEEN ASYMPTOMATIC AND SYMPTOMATIC SARS-COV-2 SEROPOSITIVE HEALTHCARE WORKERS
SHM Converge 2021
Background: Data about seroprevalence of COVID-19 infections in US Health Care Workers (HCW) is limited. CDC reported that about 55% of SARS-CoV-2 PCR positive HCWs reported exposure at work, with most of them being minimally symptomatic or asymptomatic(1). This study characterizes the symptomatic/asymptomatic SARS-CoV-2 seropositive frontline HCW in our hospital and correlate clinical features with […]
Abstract Number: 88
HIGHER ALBUMIN LEVELS ON ADMISSION PREDICT BETTER PROGNOSIS IN PATIENTS WITH CONFIRMED COVID-19
SHM Converge 2021
Background: Research surrounding COVID-19 (coronavirus disease 2019) is rapidly increasing, including the study of biomarkers for predicting outcomes. There is little data examining the correlation between serum albumin levels and COVID-19 disease severity. The purpose of this study is to evaluate whether admission albumin levels reliably predict outcomes in COVID-19 patients. Methods: We retrospectively reviewed […]
Abstract Number: 90
ASSOCIATION OF THERAPEUTIC ANTICOAGULATION WITH BLEEDING, TRANSFUSION REQUIREMENT, AND HEMATOLOGIC LAB ABNORMALITIES IN HOSPITALIZED PATIENTS WITH COVID-19
SHM Converge 2021
Background: Patients with COVID-19 have increased rates of venous thromboembolism, however, there is currently no standardized approach to anticoagulation (AC) therapy particularly with respect to the proper dose of anticoagulation (prophylactic or therapeutic). Many observational studies have shown a mortality benefit in using prophylactic AC for hospitalized patients with COVID-19. A few studies have reported […]
Abstract Number: 93
RELATIONSHIP BETWEEN SERUM SODIUM AND MORTALITY IN PATIENTS HOSPITALIZED WITH COVID-19 INFECTION
SHM Converge 2021
Background: The SARS-CoV-2 (COVID-19) outbreak is rapidly spreading worldwide and as a result clinical predictors of disease severity are critical for appropriate management and disposition of patients. An early and accurate risk stratification of COVID-19 patients may have a great impact on their prognosis given rapid patient deterioration and continued need for rationing of treatments. […]
Abstract Number: 95
CHARACTERISTICS OF SEVERE COVID-19 PNEUMONIA PATIENTS MANAGED WITHOUT INTUBATION
SHM Converge 2021
Background: Throughout the COVID-19 pandemic, the practice of intubation for hypoxemic respiratory failure secondary to presumed COVID ARDS has shifted from earlier to later intubation at our hospital. Patients are now intubated for respiratory fatigue rather than for only hypoxemia. Timing of intubation has not been associated with change in mortality based on one recent […]
Abstract Number: 96
COVID-19 TESTING: IMPLICATIONS AND CHARACTERISTICS OF FALSE NEGATIVE RESULTS
SHM Converge 2021
Background: The COVID-19 RT-PCR test is a real-time reverse transcription polymerase chain reaction (rRT-PCR) test for the qualitative detection of nucleic acid from SARS-CoV-2 virus (8). False negative RT-PCR tests pose a serious challenge as they can lead to diagnosis and treatment delays as well as increased risk of viral transmission in the community (1-10). […]
Abstract Number: 99
PREDICTORS OF MORTALITY IN CRITICALLY ILL PATIENTS ON MECHANICAL VENTILATION DUE TO COVID19 INFECTION
SHM Converge 2021
Background: On March 7, New York was declared in “State of Emergency”; all Emergency Room and hospital facilities in NYC were overwhelmed by the rapid and high influx of patients with COVID-19 infection. At least 20% of patients with criteria for hospitalization received mechanical ventilation, and the Mortality reached 80% in a time when the […]
Abstract Number: 100
PRONE POSITIONING AND ARDS PROTOCOL IN SEVERE ACUTE RESPIRATORY DISTRESS SYNDROME IN MECHANICALLY VENTILATED PATIENTS DUE TO COVID 19 INFECTION
SHM Converge 2021
Background: ARDS incidence in patients with COVID-19 pneumonia varies from 15-42%; between 5-20% of patients with hospitalization criteria received mechanical ventilation (1-3). Prone positioning demonstrated mortality benefits for patients with Severe ARDS (sARDS) with lung injury, but its use in patient COVID-19 is not clear (4-6). ARDS protocol (ARDSp) is recommended by ATS and The […]
‹ Previous
1
2
3
4
5
…
11
Next ›
Page load link
Go to Top